CytoDyn Market Cap

CytoDyn has a market cap or net worth of $290.91 million as of March 9, 2026. Its market cap has decreased by -5.03% in one year.

Market Cap

290.91M

Enterprise Value

313.20M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.23

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 290.91M, an increase of 5,153.48%. That is a compound annual growth rate of 21.53%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	296.04M	-16.74%
Dec 31, 2025	355.55M	164.08%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Silence Therapeutics	294.27M
Northwest Biotherapeutics	360.57M
Vaxart	177.30M
HST Global	88.40M
BioStem Technologies	87.58M
Nuo Therapeutics	60.36M
Vicapsys Life Sciences	48.56M
Cell Source	48.33M

Market Cap Rankings